Uphouse Lynda, Wolf Amy
Department of Biology, Texas Woman's University, Denton, TX 76204, USA.
Brain Res. 2004 Jul 9;1013(2):260-3. doi: 10.1016/j.brainres.2004.04.013.
Sexually receptive proestrous rats with bilateral cannulae in the ventromedial nucleus of the hypothalamus (VMN) were infused with 200 ng of (+/-)-8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) or with 8-OH-DPAT plus varying concentrations (200 to 2000 ng) of the 5-HT1A receptor antagonist, N-[2[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]N-(2-pyridinyl)cyclohexanecarboxamide trihydrochloride (WAY100635). 8-OH-DPAT inhibited lordosis behavior within 15 min of the infusion and every dose of WAY100635 prevented the inhibition. When non-sexually receptive, ovariectomized rats, hormonally primed with 0.5 microg estradiol benzoate and 500 microg progesterone, were infused with WAY100635 (400 to 2000 ng), the 5-HT1A receptor antagonist did not facilitate lordosis responding. These findings support earlier findings that activation of 5-HT1A receptors in the mediobasal hypothalamus inhibits lordosis behavior. However, they further demonstrate that tonic activation of 5-HT1A receptors is not responsible for the absence of sexual receptivity in suboptimally hormonally primed ovariectomized rats.
对下丘脑腹内侧核(VMN)植入双侧套管的处于发情前期且具有性接受能力的大鼠,分别注射200纳克的(±)-8-羟基-2-(二正丙基氨基)四氢萘(8-OH-DPAT),或注射8-OH-DPAT加不同浓度(200至2000纳克)的5-HT1A受体拮抗剂N-[2[4-(2-甲氧基苯基)-1-哌嗪基]乙基]N-(2-吡啶基)环己烷甲酰胺三盐酸盐(WAY100635)。8-OH-DPAT在注射后15分钟内抑制了脊柱前凸行为,而每一剂WAY100635都能阻止这种抑制作用。当对未处于性接受状态、经0.5微克苯甲酸雌二醇和500微克孕酮激素预处理的去卵巢大鼠注射WAY100635(400至2000纳克)时,这种5-HT1A受体拮抗剂并未促进脊柱前凸反应。这些发现支持了早期的研究结果,即中基底下丘脑5-HT1A受体的激活会抑制脊柱前凸行为。然而,它们进一步证明,5-HT1A受体的持续性激活并非激素预处理不足的去卵巢大鼠缺乏性接受能力的原因。